Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CORONASDAQ:PHAR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCOROiShares International Country Rotation Active ETF$27.28+0.5%$25.47$22.54▼$27.33$6.55MN/A365 shs543 shsPHARPharming Group$10.43-0.7%$8.77$6.65▼$11.07$709.22M-0.086,472 shs1,290 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCOROiShares International Country Rotation Active ETF-0.11%+0.85%+9.47%+6.85%+2,727,999,900.00%PHARPharming Group-0.71%+10.54%+26.06%+16.48%+12.46%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCOROiShares International Country Rotation Active ETFN/AN/AN/AN/AN/AN/AN/AN/APHARPharming Group1.787 of 5 stars3.53.00.00.00.00.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCOROiShares International Country Rotation Active ETF 2.70Moderate Buy$27.28N/APHARPharming Group 3.00Buy$30.00187.77% UpsideCurrent Analyst Ratings BreakdownLatest CORO, ZPHR, PHAR, and CASP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/20/2025PHARPharming GroupHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$37.00 ➝ $37.003/14/2025PHARPharming GroupOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$30.00 ➝ $39.003/14/2025PHARPharming GroupHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$37.00 ➝ $37.00(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCOROiShares International Country Rotation Active ETFN/AN/AN/AN/AN/AN/APHARPharming Group$320.71M2.21$0.11 per share91.82$3.26 per share3.20Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCOROiShares International Country Rotation Active ETFN/AN/A0.00∞N/AN/AN/AN/AN/APHARPharming Group-$10.55M-$0.20N/A347.50N/A-6.09%-7.65%-3.82%7/30/2025 (Estimated)Latest CORO, ZPHR, PHAR, and CASP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025PHARPharming Group-$0.25-$0.22+$0.03-$0.22$67.74 million$79.09 million3/13/2025Q4 2024PHARPharming Group$0.07$0.05-$0.02$0.05$76.67 million$92.70 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCOROiShares International Country Rotation Active ETF$0.361.32%N/AN/AN/APHARPharming GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCOROiShares International Country Rotation Active ETFN/AN/AN/APHARPharming Group0.413.532.76Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCOROiShares International Country Rotation Active ETFN/APHARPharming Group0.03%Insider OwnershipCompanyInsider OwnershipCOROiShares International Country Rotation Active ETFN/APHARPharming Group2.07%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCOROiShares International Country Rotation Active ETFN/A240,000N/AN/APHARPharming Group28068.03 million66.62 millionNot OptionableCORO, ZPHR, PHAR, and CASP HeadlinesRecent News About These CompaniesQ2 EPS Estimates for Pharming Group Decreased by AnalystMay 13, 2025 | marketbeat.comPharming Group First Quarter 2025 Earnings: US$0.022 loss per share (vs US$0.019 loss in 1Q 2024)May 10, 2025 | finance.yahoo.comPharming Group N.V. (PHAR) Q1 2025 Earnings Call TranscriptMay 9, 2025 | seekingalpha.comPharming Group N.V. 2025 Q1 - Results - Earnings Call PresentationMay 9, 2025 | seekingalpha.comPharming Group’s Strong Financial Performance and Strategic Growth Drive Buy RatingMay 8, 2025 | tipranks.comPharming Group N.V.: Pharming Group reports first quarter 2025 financial results and provides business updateMay 8, 2025 | finanznachrichten.dePharming Group reports first quarter 2025 financial results and provides business updateMay 8, 2025 | taiwannews.com.twPharming Group reports first quarter 2025 financial results and provides business update | ...May 8, 2025 | gurufocus.comEarnings To Watch: Pharming Group (PHGUF) Reports Q1 2025 ResultMay 7, 2025 | gurufocus.comPharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive DirectorApril 30, 2025 | finance.yahoo.comPharming Group (NASDAQ:PHAR) Sees Unusually-High Trading Volume - What's Next?April 30, 2025 | marketbeat.comPharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of ...April 30, 2025 | gurufocus.comShort Interest in Pharming Group (NASDAQ:PHAR) Declines By 36.0%April 30, 2025 | marketbeat.comPharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical ...April 25, 2025 | gurufocus.comPharming Group to Present Key Findings at Clinical Immunology Society MeetingApril 25, 2025 | tipranks.comPharming receives positive recommendation from NICE for Joenja®?(leniolisib) as a treatment for APDSApril 24, 2025 | tmcnet.comPharming receives positive recommendation from NICE for Joenja to treat APDS in adult and paediatric patients 12 years of age and olderApril 24, 2025 | pharmabiz.comPharming Group to report first quarter 2025 financial results on May 8 | PHARM Stock NewsApril 24, 2025 | gurufocus.comPharming Group to report first quarter 2025 financial results on May 8 | PHARM Stock NewsApril 24, 2025 | gurufocus.comPharming receives positive recommendation from NICE for Joenja® (leniolisib) as a treatment for APDSApril 23, 2025 | manilatimes.netPharming Group (PHAR) Receives NICE Approval for Joenja in England and Wales | PHAR Stock NewsApril 23, 2025 | gurufocus.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesArcher Aviation Gets Analyst Target Upgrade: Time to Load Up?By Jeffrey Neal Johnson | April 25, 2025View Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t IgnoreBy Sam Quirke | May 14, 2025View Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t IgnoreThese Are the Only 6 Stock Stocks in NVIDIA's 13F PortfolioBy Leo Miller | May 22, 2025View These Are the Only 6 Stock Stocks in NVIDIA's 13F Portfolio3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S.By Leo Miller | April 28, 2025View 3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S.Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?By Leo Miller | May 6, 2025View Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?CORO, ZPHR, PHAR, and CASP Company DescriptionsiShares International Country Rotation Active ETF NASDAQ:CORO$27.28 +0.13 (+0.48%) As of 05/23/2025 03:21 PM EasternThe iShares International Country Rotation Active ETF (CORO) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed fund-of-funds, seeking long-term capital appreciation through investments in non-US companies. The fund targets nations with favorable economic outlooks by employing a country rotation strategy. CORO was launched on Dec 3, 2024 and is issued by BlackRock.Pharming Group NASDAQ:PHAR$10.42 -0.08 (-0.71%) Closing price 05/23/2025 03:52 PM EasternExtended Trading$10.42 0.00 (0.00%) As of 05/23/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain Advance Auto Parts Jumps on Surprise Earnings Beat Costco Stock at $1K: Dominance or Danger Zone? Williams-Sonoma: A Fundamentally Good Buy On Sale Now Snowflake Breaks Out! Can It Drift Higher in 2025 and Beyond? Alphabet Gets JPMorgan’s Vote of Confidence After Google I/O Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
